CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

The study will evaluate the performance of the investigational TactiFlex™ Ablation Catheter, Sensor Enabled™ for people whose AFib symptoms are unable to be managed by medication.

"We are thrilled to have had a record number of MolecuLight-based clinical posters and presentations, from so many wound care professionals and settings, be included at the SAWC's Virtual Session", says Anil Amlani, MolecuLight's CEO.

LuViva will be studied to assess its ability to help detect a significant number of the up to 40% to 50% cases missed at the point of biopsy because of limitations in current imaging technology.

The study was led by Dr. Liron Pantanowitz and Dr. Rajiv Dhir, pathologists at UPMC Shadyside Hospital, who provided blinded whole slide images of prostate core needle biopsies for analysis by Ibex's Galen™ Prostate solution.

REACH PVI study prospectively evaluated acute clinical outcomes of orbital atherectomy via transradial access for the treatment of peripheral artery disease (PAD) in lower extremity lesions.

The RNS® System has been shown to dramatically reduce seizures and improve quality of life for people living with refractory epilepsy.

Published in the Journal of Pain Research, the study shows that patients using Kaia back pain app reduced pain levels, anxiety, depression, stress, and improved wellbeing and body functionality significantly more compared to standard-of-care treatments.

The SELUTION SLR™ Study involves up to 132 patients across a number of centres in Japan. Its objective is to assess the safety and efficacy of SELUTION SLR for the treatment of lesions of superficial femoral arteries and/or popliteal arteries.

The authors concluded that “Our results encourage us to strengthen screening for CCHD by adding pulse oximetry to the routine newborn screening panel.”